Your browser doesn't support javascript.
loading
Use of FRAX®-based fracture risk assessments to identify patients who will benefit from osteoporosis therapy.
Silverman, Stuart L; Komm, Barry S; Mirkin, Sebastian.
Affiliation
  • Silverman SL; Cedars-Sinai Medical Center and University of California, Los Angeles, CA, USA. Electronic address: stuarts@bhillsra.com.
  • Komm BS; Pfizer Inc., Collegeville, PA, USA. Electronic address: Barry.Komm@pfizer.com.
  • Mirkin S; Therapeutics MD, Boca Raton, FL, USA. Electronic address: Mirkin.Sebastian@gmail.com.
Maturitas ; 79(3): 241-7, 2014 Nov.
Article in En | MEDLINE | ID: mdl-25124532
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Bone Density Conservation Agents / Osteoporotic Fractures Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Maturitas Year: 2014 Document type: Article Country of publication: Ireland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Bone Density Conservation Agents / Osteoporotic Fractures Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Maturitas Year: 2014 Document type: Article Country of publication: Ireland